CAS: 225785-54-6; 3-Methyl 5-Propyl 2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3,5-Dicarboxylate

该化合物是一种二丙钙管阻塞剂,二丙烯丙烯丙烯酯合成衍生物,主要用于研究和制药开发,因为它的药理动力特性有所改变,与母分子相比,可能会提高溶性或生物利用率,其结构允许与L型钙管有选择地互动,使其成为研究心血管机制的候选体.丙基酯组引入了潜在的代谢稳定性,便利了实验环境中的长期活动.该化合物在针对高血压和相关血管紊乱的临床前调查中很受关注,由于对光和湿度的敏感性,通常在受控制的条件下处理.

结构式图片

上下游产品

3-Amin°Crotonsaeure-propylester methyl 2-(3-nitrophenylmethylene)acetoacetate 3-nitro-benzaldehyde acetoacetic acid methyl ester

合成工艺路线路线简述

    📜间硝基苯甲醛置于哌啶,溶剂黄146体系中,用 乙醇 用作溶剂,化学反应 6.0H,反应生成尼群地平丙酯
    参考文献:Synthesis And Antihypertensive Activity Evaluation In Spontaneously Hypertensive Rats Of Nitrendipine Analogues
    标题:Synthesis And Antihypertensive Activity Evaluation In Spontaneously Hypertensive Rats Of Nitrendipine Analogues
    摘要:The Antihypertensive Activity Of Nitrendipine Analogues Can Be Improved By Properly Lengthening Its Alkyl Chain In 3-Or 5-Position. Nitrendipine And Its Seven Analogues Were Synthesized,And Their Antihypertensive Activities In Spontaneously Hypertensive Rats (Shr) Were Evaluated By Ig Administration. It Was Found That 5-N-Heptyl 3-Methyl 2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3,5-Dicarboxylate [(+/-)-5] Exhibited The Strongest Antihypertensive Effect Amongst Eight Compounds. (+)-5-N-Heptyl 3-Methyl 2,6-Dimethyl-4-(3-Nitrophenyl)-1,4-Dihydropyridine-3,5-Dicarboxylate [(+)-5] Was Also Prepared. Antihypertensive Activities Of (+/-)-5 And (+)-5 In Shr Were Compared. The Results Showed That (+/-)-5 And (+)-5 Had A Higher Potency Than Nitrendipine,And (+)-Isomer Was 1.79-Fold The Raceme At A Dose Of 2 Mg/kg.
    Doi:10.1007/s00044-010-9477-0

    海关参考信息

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/s00044-010-9477-0
    摘要:Zhou K, Wang X, Zhao Y, Cao Y, Fu Q, Zhang S. Synthesis and antihypertensive activity evaluation in spontaneously hypertensive rats of nitrendipine analogues. Medicinal Chemistry Research. 2010 Oct 28;20(8):1325–30. doi: 10.1007/s00044-010-9477-0.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知